Republicans and Democrats find a unifying target: Pharmacy benefit managers

Both Republicans and Democrats are increasingly focusing on pharmacy benefit managers (PBMs) as a common issue, criticizing their role in driving up drug prices and complicating patient access to medications. States like Tennessee and Arkansas have started regulating these companies, reflecting a bipartisan push for reform. This growing consensus highlights the PBMs' outsized influence on healthcare costs and patient care, signaling a potential shift in how healthcare is managed and regulated.